Literature DB >> 7244427

Oronasal distribution of respiratory airflow.

V Niinimaa, P Cole, S Mintz, R J Shephard.   

Abstract

The oronasal distribution of respiratory airflow was determined during incrementally graded submaximal exercise in 30 (14 M, 16 F) healthy adult volunteers. Nasal airflow was measured by a pneumotachograph attached to a nasal mask. Oral airflow was determined as the difference between nasal airflow and total pulmonary airflow, the latter being measured by a head-out exercise body plethysmograph. The two airflow signals were sampled every 20 msec by a microprocessor, which calculated the oral and nasal minute volumes (separating inspiration and expiration) and produced an on-line print-out of the results. Twenty subjects ("normal augmenters") switched from nasal to oronasal breathing at a VE of 35.3 +/- 10.8 1 . min-1, four subjects ("mouth breathers") habitually breathed oronasally, five subjects ("nose breathers") persistently breathed through the nose only, and one subject showed no consistent nose/mouth breathing pattern. After the switch to oronasal breathing, the nasal portion of VE decreased suddenly to 57% of total VE. With a further increase of VE, oral minute volume increased rapidly, equalling nasal minute volume at a VE of 45 1 . min-1, and accounting for 61% of the total ventilation at high respiratory minute volumes (90 1 . min-1). During oronasal breathing, normal augmenters inspired some 2 1 . min-1 more nasally than they expired. Similarly, the nasal inspiration of mouth breathers exceeded expiration by 2 1 . min-1 at rest, but the difference increased to 13.51 . min-1 at a VE of 81.51 . min-1.

Entities:  

Mesh:

Year:  1981        PMID: 7244427     DOI: 10.1016/0034-5687(81)90089-x

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  12 in total

Review 1.  Monitoring personal allergen exposure.

Authors:  T O'Meara; E Tovey
Journal:  Clin Rev Allergy Immunol       Date:  2000-06       Impact factor: 8.667

2.  Oral airway flow dynamics in healthy humans.

Authors:  T C Amis; N O'Neill; J R Wheatley
Journal:  J Physiol       Date:  1999-02-15       Impact factor: 5.182

3.  [Mechanisms of supralaryngeal airway obstruction in normal persons and habitual mouth breathers].

Authors:  W Chowanetz; J Schott; B Jany
Journal:  Klin Wochenschr       Date:  1987-03-16

4.  Alternative approaches for acute inhalation toxicity testing to address global regulatory and non-regulatory data requirements: An international workshop report.

Authors:  Amy J Clippinger; David Allen; Annie M Jarabek; Marco Corvaro; Marianna Gaça; Sean Gehen; Jon A Hotchkiss; Grace Patlewicz; Jodie Melbourne; Paul Hinderliter; Miyoung Yoon; Dongeun Huh; Anna Lowit; Barbara Buckley; Michael Bartels; Kelly BéruBé; Daniel M Wilson; Ian Indans; Mathieu Vinken
Journal:  Toxicol In Vitro       Date:  2017-12-22       Impact factor: 3.500

Review 5.  Sleep apnea and its causes.

Authors:  N S Cherniack
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

Review 6.  [Treating nasal obstruction in obstructive sleep apnea patients].

Authors:  T Verse; S Wenzel
Journal:  HNO       Date:  2017-02       Impact factor: 1.284

7.  Development of a rhesus monkey lung geometry model and application to particle deposition in comparison to humans.

Authors:  Bahman Asgharian; Owen Price; Gene McClellan; Rick Corley; Daniel R Einstein; Richard E Jacob; Jack Harkema; Stephan A Carey; Edward Schelegle; Dallas Hyde; Julia S Kimbell; Frederick J Miller
Journal:  Inhal Toxicol       Date:  2012-11       Impact factor: 2.724

8.  Breathing-valve encumbrance and arterial blood gas and acid-base status in exercise in man.

Authors:  S A Ward; K Wasserman; J A Davis; B J Whipp
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

9.  Dental amalgam and mercury.

Authors:  A M Aronsson; B Lind; M Nylander; M Nordberg
Journal:  Biol Met       Date:  1989

10.  Thoracic and respirable particle definitions for human health risk assessment.

Authors:  James S Brown; Terry Gordon; Owen Price; Bahman Asgharian
Journal:  Part Fibre Toxicol       Date:  2013-04-10       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.